This study is in progress, not accepting new patients
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
Summary
- Eligibility
- for people ages 18-50 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
- Principal Investigator
- by Bruce Cree (ucsf)
Description
Summary
Details
Keywords
Eligibility
Location
Lead Scientist at University of California Health
- Bruce Cree (ucsf)
Bruce Cree, MD, PhD, MAS is a Professor of Clinical Neurology and is the George A. Zimmermann Endowed Professor in Multiple Sclerosis in the Department of Neurology at the University of California San Francisco. Dr. Cree completed his MD and PhD in Biochemistry at UCSF. His neurology residency training was at Columbia University.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Francisco
- ID
- NCT04466150
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 30 study participants
- Last Updated